TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Suitability of instrumentation for knee implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: rate of growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Autonomic Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: immunologic effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Recurrent urinary tract infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of patients achieving and maintaining MMR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Patients Who Complete an Accelerated Infusion Regimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delirium Rating Scale-98
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mellow and Pinkas Dysphagia Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants to be Colectomy Free at 3 Months
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With the Need for Colectomy Assessed by Biomarker Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: NCT-A test outcome measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DST test outcome measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number cancellation test outcome measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree Of Lens Deposits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion Of Participants With Eyes With Grade >2 Slit Lamp Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: improvements in prebronchodilator FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: improvements in FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Spherical Equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fractional anisotropy (FA) in the caudal portion of substantia nigra
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Participants With a Partial Response and Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of calcitriol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Women With Clinical Cure at the End of Treatment Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with treatment-related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: EGFR mutation status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of TBW volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Required to Perform Procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CNS Overall Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blooding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cytokine levels (TNF-alpha, IL-1, IL-2, IL-6, IL-8)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maximal oxygen consumption (VO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Measurement of pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: H.Pylori Infection Eradication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Less use of postoperative opioids
Endpoint domain: Adverse events/effects
Primary endpoint: Less visual analog scale (VAS) and verbal rating scale (VRS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Occurrence of opioid use
Endpoint domain: Adverse events/effects
Primary endpoint: CNS Glutamate Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequencies of positive responses to ASQ and SIQ items
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Synovitis (RAMRIS Score) at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Synovitis (RAMRIS Score) at Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Synovitis (RAMRIS Score) at Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Synovitis (RAMRIS Score) at Week 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Synovitis (RAMRIS Score) at Week 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum pepsinogen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Safety Outcome Measurement
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetic Parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to sustained improvement in clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total Transfusion Amounts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: frequency of iatrogenic urinary tract injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of Complete Response to Protocol Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCEF of RC in ALS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCEF of VC in ALS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCEF of RC in healthy subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCEF of VC in healthy subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rate after venous surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Complications after venous surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment success with first CSL689 injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contrast Sensitivity (Mesopic)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation at sports
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Occurrence of hypoglycemia or hyperglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and tolerability of PU-AD
Endpoint domain: Adverse events/effects
Primary endpoint: total number of mucosal immune cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Possible Delayed Recall Toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Secondary influenza infection
Endpoint domain: Adverse events/effects
Primary endpoint: Weight-bearing pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient in treatment failure requiring ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ventilation-support free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Vineland Adaptive Behavior Scales V-scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Primary patency of the treated site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: proportion of circulating T follicular helper lymphocytes (TFH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Weight for height z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Summed Pain Intensity Difference (SPID) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Index of successful innervated reconstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodynamic assessment (preload, afterload, contractility)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complication rate, post-operative
Endpoint domain: Adverse events/effects
Primary endpoint: Complication rate, 30 day
Endpoint domain: Adverse events/effects
Primary endpoint: Complication rate, 90 days
Endpoint domain: Adverse events/effects
Primary endpoint: Change of intact parathyroid hormone (iPTH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Muscle pain sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of emergency services
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change from baseline for EMG activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Participants Who Developed ≥Grade 2 Cytokine Release Syndrome (CRS)
Endpoint domain: Adverse events/effects
Primary endpoint: Functional Assessment of Cancer Treatment - General scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Thickness of optical fibres measured in OCT RNFL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cmax,u
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCu
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean IDAS-GD Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of B-cells of all lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of class switched memory B-cells as a percentage of B-cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cervix elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervix Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work Of Breathing (WOB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 3-years recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: Ulcer Healing Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients not requiring additional immunosuppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants with high vascular indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Hamstrings flexibility change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device function change relative to pre-scan function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lead function change relative to pre-scan function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Clinician's Erythema Assessment (CEA) Scale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Volume of fluids administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-months survival
Endpoint domain: Mortality/survival
Primary endpoint: stiffness severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diameter change of retinal vessel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Ultrasound measurement of inter-recti distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse cardiovascular event according to stenosis and plaque features
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse cardiovascular event according to pre-PCI FFR in vessels with low post-PCI FFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: one-year change in body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement from pre-test to post-test
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Assessment of range of motion of elbow, knee and ankle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of muscle strength of arm, thigh and leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of perceived quality of life for patients with hemophilia
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Extent of epidural fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of Acute GVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Safety Defined by Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of Acute GVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients receiving dementia reviews
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Days alive and not receiving organ support in ICU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects who become spasm-free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose of docetaxel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alveolar-capillary gas exchange
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Biopsy sample description accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: on-going pregnancy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of Participants Experiencing any Treatment-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants Experiencing any Treatment-Emergent Graded Laboratory Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Change of blood pressure upon initiation of pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Assessment of any adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: subjective global assessment questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: gravimetric analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified starch-iodine test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of IOS after BPT/BDT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of spirometry after BPT/BDT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Decisional conflict regarding treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk of Crohn's Disease-related complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resolving of macular edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Total Number of Polypectomies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in proportion of pills taken
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional outcome including pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Concordance Between Investigational Allergen and Reference Allergen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post operative pain evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytogenetic results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of glucose, amino acid, and lipid metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Average Daily Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 Day Post Operative Complications
Endpoint domain: Adverse events/effects
Primary endpoint: postoperative perfusion index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant hemorrhagic events
Endpoint domain: Adverse events/effects
Primary endpoint: Vocal cord dysfunction prediction accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Serious Adverse Drug Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Microaspiration of Gastric Contents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of children with moyamoya
Endpoint domain: Mortality/survival
Primary endpoint: Body Mass Index changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood loss after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk motor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilation function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: extra-vascular lung water
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in pain subscore of WOMAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Composite Autonomic Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Functional Disability Inventory
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Children's Depression Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reflux Disease Questionnaire (RDQ) score improvement ratio
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reflux Symptoms Index (RSI) threshold score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastroesophageal Reflux Disease Health-Related Quality of Life (GORD-HRQL) threshold scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: change in disease severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day physical activity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day physical activity recall (PAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delta Event/Alpha Event Ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perioperative Morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of computed tomography (CT) findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum lactate clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in degree of tinnitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Height SDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in EORTC QLQ-H&N35 index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percent change in FDG-PET standardized uptake value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in markers of proliferation (Ki67)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum inflammatory adhesion molecules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Variation in prolactin serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: glycated albumin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Wall to lumen ratio (WLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart failure diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from patency-related intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Highest and safest dose of LBH589
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HE-4 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Oswestry Disability Index 2.1 (ODI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning